“Lipid Profile in People Starting Antiretroviral Therapy With Efavirenz or Dolutegravir Based Regimens from a Reference Center in Brazil: A Cohort Study”. 2022. Research, Society and Development 11 (5): e55811528662. https://doi.org/10.33448/rsd-v11i5.28662.